Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Cash from Operations (2016 - 2025)

Avalo Therapeutics' Cash from Operations history spans 12 years, with the latest figure at 14288000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 5.03% year-over-year to 14288000.0; the TTM value through Dec 2025 reached 51500000.0, down 4.98%, while the annual FY2025 figure was 51500000.0, 4.98% down from the prior year.
  • Cash from Operations reached 14288000.0 in Q4 2025 per AVTX's latest filing, up from 16365000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 5726000.0 in Q3 2022 to a low of 19187000.0 in Q2 2021.
  • Average Cash from Operations over 5 years is 11443950.0, with a median of 11998500.0 recorded in 2022.
  • Peak YoY movement for Cash from Operations: skyrocketed 135.15% in 2022, then plummeted 443.89% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 17099000.0 in 2021, then skyrocketed by 76.96% to 3940000.0 in 2022, then grew by 29.8% to 2766000.0 in 2023, then tumbled by 443.89% to 15044000.0 in 2024, then increased by 5.03% to 14288000.0 in 2025.
  • Per Business Quant, the three most recent readings for AVTX's Cash from Operations are 14288000.0 (Q4 2025), 16365000.0 (Q3 2025), and 11347000.0 (Q2 2025).